Overview

PP-Gemcitabine & External Beam Radiation-Sarcomas

Status:
Completed

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to find the highest safe dose of gemcitabine that can be given with radiotherapy before surgery to treat sarcoma. This study will also look at how well this treatment controls sarcoma.

Phase:

Phase 1

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

Eli Lilly and Company

Treatments:

Gemcitabine